Valneva Announces EMA Approval of IXIARO® Shelf Life Extension to 36 Months
Valneva announced that the European Medicines Agency (EMA) has approved the extension of the shelf life of its Japanese encephalitis vaccine IXIARO® from 24 months to 36 months.